Finance Home - My Yahoo - Yahoo! - Help

Sunday, December 6, 2009, 9:12PM ET - U.S. Markets Closed. Dow  0.22% Nasdaq  0.98%

NovaBay Pharmaceuticals, Inc. (NBY)

On Dec 4: 2.00   0.049 (2.39%)

MORE ON NBY

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Tue, Nov 17, 2009 • NOVABAY PHARMACEUTICALS, INC. Financials EDGAR Online Financials (Tue, Nov 17) Mon, Nov 16, 2009 • New Star Analyst Rankings for NOVABAY PHARMACEUTCL StarMine (Mon, Nov 16) Fri, Nov 13, 2009 • NovaBay Pharmaceuticals Reports Third Quarter Financials and Provides Update on Pipeline of Anti-Infective Compounds Marketwire (Fri, Nov 13) Thu, Nov 12, 2009 • NOVABAY PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online (Thu, Nov 12) Fri, Oct 30, 2009 • NovaBay's Aganocides Show Penetration and Efficacy in a Pre-Clinical Infected Human Nail Model of Onychomycosis PR Newswire (Fri, Oct 30) Wed, Oct 28, 2009 • NovaBay to Hold Conference Call to Review Aganocide Data Presented at the Infectious Diseases Society of America Meeting PR Newswire (Wed, Oct 28) Thu, Oct 22, 2009 • NovaBay Pharmaceuticals to Present at 8th Annual Bio Investor Forum 2009 in San Francisco PR Newswire (Thu, Oct 22) Mon, Oct 19, 2009 • NovaBay hires chief scientific officer at bizjournals.com (Mon, Oct 19) • NovaBay Pharmaceuticals Expands Management Team; Names Mark Anderson, Ph.D. as Chief Scientific Officer PR Newswire (Mon, Oct 19) Thu, Sep 24, 2009 • NovaBay Pharmaceuticals to Present at Maxim Group Growth Conference PR Newswire (Thu, Sep 24) Mon, Sep 14, 2009 • NovaBay(R) Presents Data Confirming Its Aganocide(R) Compounds Are Effective In Killing Bacteria That Have Developed Multidrug-Resistance PR Newswire (Mon, Sep 14) Thu, Sep 10, 2009 • NovaBay Launches Clinical Study for Non-Antibiotic Treatment of Impetigo, One of the Most Common Skin Infections PR Newswire (Thu, Sep 10) Wed, Aug 26, 2009 • NovaBay Pharmaceuticals Announces the Closing of Its $2.45 Million Registered Direct Offering of Common Stock and Warrants Marketwire (Wed, Aug 26) Fri, Aug 21, 2009 • NOVABAY PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an EDGAR Online (Fri, Aug 21) • NovaBay Pharmaceuticals, Inc. Announces Pricing of Registered Direct Offering of Common Stock and Warrants Marketwire (Fri, Aug 21) Fri, Aug 14, 2009 • NOVABAY PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online (Fri, Aug 14) Tue, Aug 4, 2009 • NOVABAY PHARMACEUTICALS, INC. Files SEC form 10-Q/A, Quarterly Report EDGAR Online (Tue, Aug 4) Mon, Aug 3, 2009 • NOVABAY PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online (Mon, Aug 3) Fri, May 15, 2009 • NOVABAY PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online (Fri, May 15) Tue, Mar 31, 2009 • NOVABAY PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report EDGAR Online (Tue, Mar 31) Older Headlines - Download Recent Headlines View headlines from: Tue, Mar 31, 2009Tue, Mar 24, 2009Tue, Mar 17, 2009Tue, Mar 10, 2009Tue, Mar 3, 2009Tue, Feb 24, 2009Tue, Feb 17, 2009Tue, Feb 10, 2009Tue, Feb 3, 2009Tue, Jan 27, 2009 Add NBY News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage